QA: Verona Pharma plc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001657312_2023_Verona_Pharma_plc.pdf

Logs

Graph

Absolute values for 0001657312, Verona Pharma plc

  xvar xval
0 AssetsCurrent 242,996,000
1 IntangibleAssetsNetIncludingGoodwill 545,000
2 PropertyPlantAndEquipmentNet 73,000
3 remainder_Assets 15,854,000
4 LiabilitiesCurrent 19,029,000
5 LiabilitiesNoncurrent 9,973,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 346,000
8 SellingGeneralAndAdministrativeExpense 26,579,000
9 ResearchAndDevelopmentExpense 49,283,000
10 remainder_Expenses 253,000
11 remainder_Revenues 458,000
12 remainder_NetIncome 7,302,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 259,468,000
1 Liabilities 29,002,000
2 Expenses 76,461,000
3 Revenues 458,000
4 StockholdersEquity 230,466,000
5 NetIncome -68,701,000
6 ComprehensiveNetIncome -68,701,000
7 BaseVar 186,345,500
8 EconomicCapitalRatio 2.27

Edgar->Model Mapping

Feature Distribution

Change over Time